Kaposi's sarcoma
ICD-10 Code
C46
Kaposi's sarcoma
Definition
A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
Also known as Kaposi sarcoma, Kaposi's sarcoma, Kaposi's sarcoma (disease), KS — per MONDO
Also identified as
- DOID 8632 per MONDO
- ICD10CM C46 per MONDO
- ICD9 176 per MONDO
- ICD9 176.8 per MONDO
- ICD9 176.9 per MONDO
- MESH D012514 per MONDO
- NCIT C9087 per MONDO
- Orphanet 33276 per MONDO
- SCTID 109385007 per MONDO
- UMLS C0036220 per MONDO
Affected Organs
| Organ | Involvement | Source |
|---|---|---|
| Blood vessel | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Cardiovascular system | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
Drugs indicated
| Drug | Relation | Source |
|---|---|---|
| Alitretinoin | may treat | MEDRT · Public domain (U.S. Government work) |
| Dactinomycin | may treat | MEDRT · Public domain (U.S. Government work) |
| Daunorubicin | may treat | MEDRT · Public domain (U.S. Government work) |
| Doxorubicin | may treat | MEDRT · Public domain (U.S. Government work) |
| Etoposide | may treat | MEDRT · Public domain (U.S. Government work) |
| Interferon Alfa-N3 | may treat | MEDRT · Public domain (U.S. Government work) |
| Interferon Beta-1B | may treat | MEDRT · Public domain (U.S. Government work) |
| Interferon Gamma-1b | may treat | MEDRT · Public domain (U.S. Government work) |
| Paclitaxel | may treat | MEDRT · Public domain (U.S. Government work) |
| Peginterferon Alfa-2a | may treat | MEDRT · Public domain (U.S. Government work) |
| Vinblastine | may treat | MEDRT · Public domain (U.S. Government work) |